Search
Search Constraints
You searched for: Author/Creator Post, DianeLimit your search
- 615.372 1
- ABS Access and Benefit Sharing -- ACT Access to COVID-19 Tools -- ADCC antibody-dependent cellular cytotoxicity -- CARB-X biopharmaceutical accelerator for combating antibiotic resistant bacteria -- CEPI Coalition for Epidemic Preparedness Innovations -- CIDRAP Center for Infectious Disease Research and Policy -- CIVICs Collaborative Influenza Vaccine Innovation Centers -- COBRA computationally optimized broadly reactive antigen -- CHIVIM controlled human influenza virus infection model -- EU European Union -- FVVA full value of vaccine assessment -- GISRS Global Influenza Surveillance and Response System -- HAI hemagglutination-inhibition -- HA hemagglutinin -- HVAC heating, ventilation, and air conditioning -- IIV inactivated influenza vaccines -- IVR Influenza Vaccines Research and Development (R&D) Roadmap -- LAIV live-attenuated influenza vaccines -- LMICs low- and middle-income countries -- ME&A monitoring, evaluation, and adjustment -- NA neuraminidase -- NIAID US National Institute of Allergy and Infectious Diseases -- R&D Research and Development -- SME subject matter expert -- WHO World Health Organization 1
- Influenza -- Pandemic preparedness -- Seasonal influenza vaccines -- Universal influenza vaccines -- Broadly protective influenza vaccines -- Roadmap 1
- Vaccines -- Periodicals 1